To be Published in Gazette of India Extraordinary Part - II, Section - 3, Sub - Section (ii)

Government of India
Ministry of Commerce & Industry
Department of Commerce
Directorate General of Foreign Trade
Udyog Bhawan New Delhi

Notification No. 56/2015-2020
New Delhi, Dated: 24^th February, 2022

Subject: Amendment in Export Policy of Remdesivir Injection and API, Amphotericin-B Injections, Enoxaparin (Formulation and API) and Intra-Venous Immunoglobulin (IVIG) (Formulation and API) - regarding

S.O. (E) In exercise of powers conferred by Section 3 read with Section 5 of the Foreign Trade (Development & Regulation) Act, 1992 (No. 22 of 1992), as amended, read with Para 1.02 and 2.01 of the Foreign Trade Policy, 2015-20, the Central Government hereby makes following amendment in Notification No. 08/2015-20 dated 14.06.2021, Notification No. 07/2015-20 dated 01.06.2021 and Notification No. 50/2015-20 dated 10.01.2022 related to export of Remdesivir Injection and API, Amphotcricin-B Injections, Enoxaparin (Formulation and API) and Intra-Venous Immunoglobulin (IVIG) (Formulation and API):

2. Effect of this Notification:

The export policy of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API), Amphotericin - B injections, Enoxaparin (Formulation and API) and Intra-Venous Immunoglobulin (IVIG) (Formulation and API) falling under IIS code as mentioned above or falling under any other IIS code has been made ‘Free’ with immediate effect.

(Santosh Kumar Sarangi)
Director General of Foreign Trade
Ex-Officio Additional Secretary, Gol
Email- dgft@nic.in

(Issued from F. No. 01/91/180/24/AM22/EC /E-27724)